SCHEMBL4904833

SCHEMBL4904833

NC(=O)C1C2CC3CC(C2)CC1(N)C3

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 2/20 0.39
CYP2C9 P11712 1/20 0.39
ALDH1A1 P00352 3/20 0.38
TSHR P16473 2/20 0.38
LMNA P02545 4/20 0.37
SLC22A2 O15244 1/20 0.37
SLC22A1 O15245 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
NFKB1 P19838 1/20 0.37
STAT6 P42226 1/20 0.37
GRIN1 Q05586 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37
GRIN3A Q8TCU5 1/20 0.37
SLC47A1 Q96FL8 1/20 0.37
SIGMAR1 Q99720 1/20 0.37
POLB P06746 1/20 0.36
BLM P54132 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11342798 0.83 THRB (0.44) THRBCYP2C9ALDH1A1TSHRLMNA
SCHEMBL28087061 0.82 THRB (0.38) THRBCYP2C9ALDH1A1TSHRLMNA
SCHEMBL3929216 0.79 ALDH1A1 (0.38) THRBCYP2C9ALDH1A1TSHRLMNA
SCHEMBL28088722 0.78 ALDH1A1 (0.38) THRBCYP2C9ALDH1A1TSHRLMNA
SCHEMBL1578432 0.78 ALDH1A1 (0.37) THRBCYP2C9ALDH1A1TSHRLMNA
SCHEMBL4541831 0.78 ALDH1A1 (0.37) THRBCYP2C9ALDH1A1TSHRLMNA
SCHEMBL27364785 0.74 MAPK1 (0.41) THRBCYP2C9EPHX2
SCHEMBL623801 0.71 THRB (0.36) THRBCYP2C9ALDH1A1TSHRLMNA
SCHEMBL1497395 0.69 LMNA (0.43) THRBCYP2C9ALDH1A1TSHRLMNA
Hydrochloric Acid SCHEMBL2807432 0.67 LMNA (0.46) THRBCYP2C9ALDH1A1TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275112-A1 Invention Concerning Aminoadamantane Compounds SCHREINER PETER R 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275112-A1 Invention Concerning Aminoadamantane Compounds GABRA5, GABRA1, GABRA4 THRB 2133/4885CYP2C9 2030/4885ALDH1A1 570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.